Pneumocystis carinii pneumonia and HIV infection: Diagnosis and treatment;Neumonia por Pneumocystis carinii e infeccion por el VIH: Diagnostico y tratamiento

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 16, Issue SUPPL. 1, 1998, Pages 36-44

  González García, Juan ^a,e   Rubio García, Rafael ^b   Antela López, Antonio ^c   García Alcaide, Felipe ^d  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; FOLINIC ACID; PENTAMIDINE; PRIMAQUINE; PYRIMETHAMINE; TRIMETREXATE; ANTIINFECTIVE AGENT; BACTERIAL DNA;

DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG LAVAGE; MORBIDITY; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; REVIEW; SPECTROSCOPY; AIDS RELATED COMPLEX; BACTERIAL PNEUMONIA; ISOLATION AND PURIFICATION; LUNG TUBERCULOSIS; MICROBIOLOGY; PNEUMOCYSTIS; POLYMERASE CHAIN REACTION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DIAGNOSIS, DIFFERENTIAL; DNA, BACTERIAL; HUMANS; PNEUMOCYSTIS; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS, PULMONARY;

EID: 0032254482     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Walzer PD. Pneumocystis carinii. En: Mandell GL, Bennett JE, Dolin R, editores. Mandell, Douglas and Benntt's principles and practice of infectious diseases (4.a ed.). Nueva York: Churcill Livingstone, 1995; 2.475-2.487.
2. Latouche S, Ortona E, Mazars E et al. Biodiversity of Pneumocystis carinii hominis typing with different DNA regions. J Clin Microbiol 1997; 35: 383-387.
3. th Conference on Retrovirus Opportunistic Infections, 1997.
4. th ICAAC, 1997.
5. Keely SP, Baughman RP, Smulian AG, Dohn MN, Stringer JR. Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS 1996; 10: 881-888.
6. Latouche S, Poirot JL, Bernard C, Roux P. Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia. J Clin Microbiol 1997; 35: 1.687-1.690.
7. th Conference on Retrovirus ad Opportunistic Infections, 1997.
8. o 4, 1997.
9. Efferen LS, Nadarajah D, Palat DS. Survival folowing mechanical ventilation for Pneumocystis Carinii pneumonia in patients with the acquired immunodeficiency syndromel: a different perspective. Am J Med 1989; 87: 401-404.
10. Friedman Y, Franklin C, Rackow EC et al. Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. Chest 1989; 96: 862-866.
11. 3. J Infect Dis 1994; 170: 1.284-1.287.
12. th Conference on Retrovirus and Opportunistic Infections, 1998.
13. Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
14. Wallace JM, Hansen NI, Lavange L et al. Respiratory disease trends in the pulmonary complications of HIV infection study cohort. Pulmonary complications of HIV infection study group. Am J Respir Crit Care Med 1997; 155: 72-80.
15. Stansell JD, Osmond DH, Charlebois E et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary complications of HIV infection study group. Am J Respir Crit Care Med 1997; 155: 60-66
16. Selwyn PA, Pumerantz AS, Durante A et al. Clinical predictors of Pneumocystis carinii pneumonia, bacterial pneumonia and tuberculosis in HIV-infected patients. AIDS 1998; 12: 885-893.
17. Sarkar S, Dubé MP, Jones BE, Sattler FR. Pneumocystis carinii pneumonia masquerading as tuberculosis. Arch Intern Med 1997; 157: 351-355.
18. Phair J, Muñoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 161-165.
19. th Conference on Retrovirus and Opportunistic Infections, 1997.
20. Schwarcz SK, Katz MH, Hirozawa A, Gurley J, Lemp GF. Prevention of Pneumocystis carinii pneumonia: who are we missing? AIDS 1997; 11: 1.263-1.268.
21. Bozzette SA. Finkelstein DM, Spector SA et al. A randomized trial of three anti-Pneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332: 693-699.
22. th Conference on Retrovirus Opportunistic Infections, 1997.
23. Saah AL, Hoover DR, Peng Y et al. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS cohort study. JAMA 1995; 237: 1.197-1.202.
24. Kroe DM. Diagnostic strategies for Pneumocystis carinii pneumonias. Semin Respir Infect 1997; 12: 70-78.
25. Boldt MJ, Bai TR. Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia. Chest 1997; 111: 1.187-1.192.
26. Brenner M, Ognibene FP, Lack EE et al. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis 1987; 136: 1.199-1.206.
27. Boiselle PM, Tocino I, Hooley RJ et al. Chest radiograph interpretation of Pneumocystis carinii pneumonia, bacterial pneumonia, and pulmonary tuberculosis in HIV-positive patients: accuracy, distinguishing features, and mimics. J Thorac Imaging 1997; 12: 47-53.
28. Kuhlman JE. Pneumocystic infections: the radiologist's perspective. Radiology 1996; 198: 623-635.
29. Schneider RF, Rosen MJ. Pulmonary complications of HIV infection. Curr Opin Pulmonary Med 1997; 3: 151-158.
30. Gruden JF, Huang L, Turner J et al. High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. Am J Roengenol 1997; 169: 967-975.
31. Jules-Erlysee KM, Stover DE, Zaman MB et al. Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia. Ann Intern Med 1990; 112: 750-757.
32. Gracia JD, Miravitlles M, Mayordomo C et al. Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients. Chest 1997; 111: 1.180-1.186.
33. Torrington KG, Finelli MR. Small volume bronchoalveolar lavage used in diagnosing Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1995; 107: 1.013-1.017.
34. Tiley SM, Marriot DJE, Harkness JL. An evaluation of four methods for the detection of Pneumocystis carinii in clinical specimens. Pathology 1995; 26: 325-328.
35. th Conference on Retroviruses and Opportunistic Infections, 1998.
36. Lu JJ, Chen Ch, Bartlett MS, Smith JW, Lee Ch. Comparison of six different PCR methods for detection of Pneumocystis carinii J Clin Microbiol 1995; 33: 2.785-2.788.
37. Mathis A, Weber R, Kuster H, Speich R. Simplified sample processing combined with a sensitive one-tube nestyed PCR assay for detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 1997; 35: 1.691-1695.
38. Ortona E, Margutti P, Tamburrini E et al. Detection of Pneumocystis carinii in respiratory specimens by PCR-solution hybridization enzyme-linked immunoassay. J Clin Microbiol 1997; 35: 1.589-1.591.
39. Weig M, Klinker H, Bogner BH, Meier A, Gross U. Usefulness of PCR for diagnosis of Pneumocystis carinii pneumonia in different patient groups. J Clin Microbiol 1997; 35: 1.445-1.449.
40. Graves DC, Chary-Reddy S, Becker-Hapak M. Detection of Pneumocystis carinii in induced sputa from immunocompromised patients using a repetitive DNA probe. Moll Cell Prob 1997; 11: 1-9.
41. Wagner D, Koniger J, Kern WV, Kern P. Serum PCR of Pneumocystis carinii DNA in immunocompromised patients. Scand J Infect Dis 1997; 29: 159-164.
42. Ioannidis JPA, Cappelleri JC, Skolnik PR, Lau J, Sacks HS. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med 1996; 156: 177-188.
43. Bucher HC, Griffith L, Guyatt GH, Opravil M. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. J AIDS HR 1997; 15: 104-114.
44. th ICAAC, 1997.
45. Viciana P, Miralles-Martín P, Knobel H, Gatell JM. Actualización de las profilaxis de las infecciones oportunistas en la era de los inhibidores de la proteasa. Enferm Infecc Microbiol Clin. (En prensa).
46. th Annual Metting, 1997.
47. Dunne MW, Havlir D, Dube M et al. Prevention of Pneumocystis carinii pneumonia with azithromicin. [resumen 410]. Vancouver: XIth Int Conf AIDS, 1996.
48. th ICAAC, 1997.
49. Santamauro JT, Stover DE. Pneumocystis carinii pneumonia. Med Clin North Am 1997; 81: 299-318.
50. a ed.). Boston: Little Brown and Company, 1994; 6.17-1-35.
51. Deresinsky. Treatment of Pneumocystis carinii pneumonia in adults with AIDS. Semin Respir Infect 1997; 12: 79-97.
52. Sattler FR. Pneumocystis carinii pneumonia. En: Broder S, Merigan TC, Bolognesi D, editores. Textbook of AIDS medicine. Baltimore: Willians and Wilkins. 1994; 193-221.
53. Safrin S, Finkelstein DM, Feinberg J et al. Comparison of three regimens for the treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med 1996; 124: 792-802.
54. Veenstra J, Veugelers PJ, Keet IP et al. Rapid disease progresion in humen immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis. Clin Infect Dis 1997; 24: 936-941.
55. Stricker RB, Gullett JH, Willians LE, Goldberg B. Co-trimoxazole desensitization syndrome: delayed hematologic toxicity complicating prophylactic therapy in AIDS patients. AIDS 1996; 10: 927-929.
56. Caumes E. Intérêt de la désensibilisation pou réintroduire le trimethopri-mesulfamethoxazole chez les patients intolérants et infectés par le VIH. Ann Med Intern 1997; 148: 172-176.
57. O'Brien JG, Dong BJ, Coleman RL, Gee L, Balano KB. A 5-years retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia. Clin Infect Dis 1997; 24: 854-859.
58. Allegra CJ, Cabner BA, Tuazon CU et al. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1987; 317: 978-985.
59. th Conference Retrovirus and Opportunistic Infections, 1997.
60. Masur H, Shelhamer J. Empiric outpatient management of HIV-related pneumonia: economical or unwise? Ann Intern Med 1996; 124: 451-453.